搜索





搜索





市场行情
/
股票
/
bdrx
/

Biodexa Pharmaceuticals PLC

BDRX

添加自选

1.310USD

-0.170-11.49%

收盘 07-31 16:00（美东）报价延迟15分钟

591.64K总市值

7.51市盈率 TTM

Biodexa Pharmaceuticals PLC

1.310

-0.170-11.49%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

BDRX 利润表

您可以在这里找到Biodexa Pharmaceuticals PLC的年度或季度收入报告，以深入了解Biodexa Pharmaceuticals PLC的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2024H2

FY2024H1

FY2023H2

FY2023H1

FY2022H2

FY2022H1

FY2021H2

FY2021H1

FY2020H2

FY2020H1

FY2019H2

FY2019H1

FY2018H2

FY2018H1

FY2017H2

FY2017H1

FY2016H2

FY2016H1

FY2015H2

FY2015H1

FY2014H2

FY2014H1

FY2013H2

FY2013H1

营业总收入

-100.00%0.00

-63.11%67.09K

-41.49%237.39K

29.19%181.89K

39.04%405.72K

11.13%140.79K

122.38%291.81K

-30.44%126.68K

-64.33%131.22K

-83.08%182.13K

-12.35%367.87K

190.87%1.08M

19.26%419.72K

-85.24%370.18K

-87.70%351.93K

240.63%2.51M

1262.44%2.86M

810.34%736.36K

813.19%210.06K

3064.73%80.89K

-74.83%23.00K

--2.56K

--91.37K

营业收入

-100.00%0.00

-63.11%67.09K

-41.49%237.39K

29.19%181.89K

39.04%405.72K

11.13%140.79K

122.38%291.81K

-30.44%126.68K

-64.33%131.22K

-83.08%182.13K

-12.35%367.87K

190.87%1.08M

19.26%419.72K

-85.24%370.18K

-87.70%351.93K

240.63%2.51M

1262.44%2.86M

810.34%736.36K

813.19%210.06K

37.60%80.89K

-34.55%23.00K

--58.79K

--35.14K

主营业务成本

----

-698.31%-293.43K

--776.64K

--49.04K

----

营业费用

22.15%3.80M

-13.00%3.15M

-26.55%3.11M

-1.70%3.62M

35.26%4.24M

39.16%3.68M

5.82%3.13M

-51.07%2.65M

-42.65%2.96M

16.63%5.41M

-3.90%5.17M

-11.08%4.64M

32.40%5.38M

-1.40%5.21M

-57.77%4.06M

-50.31%5.29M

57.66%9.61M

193.57%10.64M

35.69%6.10M

81.68%3.62M

580.13%4.49M

-13.57%1.99M

--660.70K

--2.31M

研发费用

69.16%2.48M

-9.00%1.63M

-30.90%1.47M

-14.28%1.79M

1.01%2.12M

43.02%2.09M

39.74%2.10M

-53.05%1.46M

-58.16%1.50M

10.67%3.12M

-2.61%3.60M

-19.86%2.82M

23.80%3.69M

13.20%3.51M

-19.96%2.98M

101.36%3.10M

29.81%3.73M

30.47%1.54M

2.77%2.87M

46.72%1.18M

824.32%2.79M

-13.22%805.11K

--302.24K

--927.80K

折旧摊销及损耗

-20.28%90.21K

-11.01%101.38K

-9.04%113.17K

-27.80%113.92K

-30.18%124.41K

21.13%157.78K

-61.78%178.17K

-70.90%130.26K

-11.35%466.19K

-14.61%447.55K

29.96%525.88K

-26.12%524.13K

-55.97%404.65K

-25.45%709.48K

-48.13%919.00K

-41.21%951.64K

363.18%1.77M

1207.21%1.62M

164.93%382.54K

82.83%123.83K

270.46%144.39K

-43.01%67.73K

--38.98K

--118.85K

其他营业费用

-109.43%-23.70K

----

-139.54%-11.32K

100.00%0.00

-184.85%-4.72K

38.51%-13.87K

164.10%5.57K

---22.56K

29.41%-8.69K

----

---12.31K

----

营业利润

-24.83%-3.80M

6.89%-3.15M

24.91%-3.05M

-3.22%-3.38M

-35.55%-4.06M

-39.17%-3.28M

-5.59%-2.99M

55.39%-2.35M

43.10%-2.84M

-23.60%-5.28M

-15.93%-4.98M

10.97%-4.27M

-16.50%-4.30M

2.87%-4.79M

48.07%-3.69M

36.55%-4.94M

-32.53%-7.11M

-127.81%-7.78M

-21.49%-5.36M

-73.14%-3.41M

-570.48%-4.41M

11.04%-1.97M

---658.15K

---2.22M

净非营业利息收入（费用）

利息收入

54.42%61.16K

235.31%64.11K

118.71%39.61K

267.56%19.12K

--18.11K

--5.20K

-100.00%0.00

-98.38%6.52K

-4.03%781.07

51864.07%402.82K

6.45%813.87

-99.73%775.19

-92.66%764.53

-37.44%287.68K

-98.19%10.42K

-60.53%459.84K

3071.33%575.71K

28948.81%1.17M

1320.51%18.15K

-98.54%4.01K

--1.28K

--275.40K

----

利息费用

-50.22%7.65K

-53.21%8.20K

-32.74%15.36K

-15.77%17.53K

24.82%22.83K

29.96%20.81K

2427.22%18.29K

-6.83%16.01K

-99.16%723.90

31.96%17.18K

-67.98%86.14K

-92.90%13.02K

681.14%268.99K

304.27%183.49K

-41.32%34.44K

--45.39K

--58.69K

----

-86.47%7.78K

-80.71%47.46K

--57.51K

--246.01K

----

出售证券收益

-1112.00%-81.80K

---26.84K

--8.08K

----

100.26%795.42

----

-2399.67%-301.87K

----

--13.13K

--6.51K

----

--4.90K

----

---274.76K

特殊收入（费用）

2210.17%1.89M

82.06%559.82K

48.12%81.64K

-10.88%307.50K

-93.52%55.12K

453.84%345.04K

191.49%851.10K

98.87%-97.51K

---930.22K

---8.66M

--0.00

----

100.00%0.00

----

88.27%-1.08M

----

---9.18M

----

-固定资产出售收益

89.16%3.06K

----

-82.89%1.62K

-100.00%0.00

114.14%9.45K

-94.33%1.73K

---66.82K

--30.56K

----

其他非经营性收入（费用）

-89.16%-3.06K

----

82.89%-1.62K

100.00%0.00

-114.14%-9.45K

94.33%-1.73K

--66.82K

---30.56K

----

税前利润

33.65%-1.95M

16.69%-2.56M

26.81%-2.93M

-4.28%-3.07M

-85.52%-4.01M

-19.41%-2.95M

46.81%-2.16M

82.32%-2.47M

12.71%-4.06M

-226.40%-13.95M

-1.90%-4.65M

14.12%-4.27M

-1.20%-4.57M

-0.12%-4.98M

71.58%-4.51M

30.99%-4.97M

-278.87%-15.88M

-111.59%-7.20M

5.95%-4.19M

-67.83%-3.40M

-608.73%-4.46M

18.59%-2.03M

---628.75K

---2.49M

所得税

-0.19%-95.57K

59.39%-93.18K

75.53%-95.38K

21.47%-229.43K

-19.51%-389.76K

-70.12%-292.15K

46.50%-326.12K

49.91%-171.74K

22.04%-609.53K

49.36%-342.89K

11.76%-781.85K

0.37%-677.14K

-98.88%-886.05K

-41.84%-679.66K

92.89%-445.51K

53.35%-479.17K

-1051.13%-6.27M

-345.06%-1.03M

-26.84%-544.38K

3.93%-230.81K

-104.77%-429.17K

20.17%-240.26K

---209.58K

---300.96K

除税后利润

34.78%-1.85M

13.24%-2.47M

21.56%-2.84M

-7.11%-2.84M

-97.25%-3.62M

-15.62%-2.65M

46.87%-1.83M

83.13%-2.30M

10.83%-3.45M

-278.32%-13.61M

-5.19%-3.87M

16.30%-3.60M

9.50%-3.68M

4.33%-4.30M

57.69%-4.07M

27.27%-4.49M

-163.59%-9.61M

-94.60%-6.17M

9.44%-3.65M

-77.47%-3.17M

-860.71%-4.03M

18.38%-1.79M

---419.17K

---2.19M

持续经营利润

34.78%-1.85M

13.24%-2.47M

21.56%-2.84M

-7.11%-2.84M

-97.25%-3.62M

-15.62%-2.65M

46.87%-1.83M

83.13%-2.30M

10.83%-3.45M

-278.32%-13.61M

-5.19%-3.87M

16.30%-3.60M

9.50%-3.68M

4.33%-4.30M

57.69%-4.07M

27.27%-4.49M

-163.59%-9.61M

-94.60%-6.17M

9.44%-3.65M

-77.47%-3.17M

-860.71%-4.03M

18.38%-1.79M

---419.17K

---2.19M

停止经营利润

----

--0.00

----

100.00%0.00

----

-188.62%-776.93K

100.00%0.00

189.79%876.74K

-98.55%-4.43M

---976.40K

---2.23M

----

归属于母公司的净利润

34.78%-1.85M

13.24%-2.47M

21.56%-2.84M

-7.11%-2.84M

-97.25%-3.62M

-15.62%-2.65M

46.87%-1.83M

83.13%-2.30M

25.73%-3.45M

-278.32%-13.61M

-65.79%-4.65M

58.78%-3.60M

44.41%-2.80M

-29.81%-8.73M

47.53%-5.04M

-8.86%-6.72M

-163.59%-9.61M

-94.60%-6.17M

9.44%-3.65M

-77.47%-3.17M

-860.71%-4.03M

18.38%-1.79M

---419.17K

---2.19M

归属于普通股东的净利润

34.78%-1.85M

13.24%-2.47M

21.56%-2.84M

-7.11%-2.84M

-97.25%-3.62M

-15.62%-2.65M

46.87%-1.83M

83.13%-2.30M

25.73%-3.45M

-278.32%-13.61M

-65.79%-4.65M

58.78%-3.60M

44.41%-2.80M

-29.81%-8.73M

47.53%-5.04M

-8.86%-6.72M

-163.59%-9.61M

-94.60%-6.17M

9.44%-3.65M

-77.47%-3.17M

-860.71%-4.03M

18.38%-1.79M

---419.17K

---2.19M

基本每股收益

96.85%0.00

100.00%0.00

99.98%-0.01

-8438.71%-46.01

-15457.63%-58.36

25.69%-0.54

68.28%-0.38

92.73%-0.73

72.56%-1.18

-736.52%-9.97

90.60%-4.31

99.17%-1.19

50.98%-45.84

-3.49%-142.84

62.38%-93.51

25.18%-138.03

-95.32%-248.54

-61.64%-184.49

65.44%-127.25

54.57%-114.13

-2341.66%-368.20

-218.83%-251.25

---15.08

---78.81

稀释每股收益

96.85%0.00

100.00%0.00

99.98%-0.01

-8438.71%-46.01

-15457.63%-58.36

25.69%-0.54

68.28%-0.38

92.73%-0.73

72.56%-1.18

-736.52%-9.97

90.60%-4.31

99.17%-1.19

50.98%-45.84

-3.49%-142.84

62.38%-93.51

25.18%-138.03

-95.32%-248.54

-61.64%-184.49

65.44%-127.25

54.57%-114.13

-2341.66%-368.20

-218.83%-251.25

---15.08

---78.81

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Biodexa Pharmaceuticals PLC 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 BDRX 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Biodexa Pharmaceuticals PLC 全年的净利润是多少？



Biodexa Pharmaceuticals PLC 2025 财年净利润为 -4.82M。

Biodexa Pharmaceuticals PLC 上一季度的净利润是多少？



Biodexa Pharmaceuticals PLC 最近一个季度的净利润为 -1.85M。

Biodexa Pharmaceuticals PLC 年度营业利润是多少？



Biodexa Pharmaceuticals PLC 2025 财年的营业利润为 -11.46M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。